Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diquas-S for Dry Eye After Cataract Surgery
NCT03640351Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Aug 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of diquafosol in dry eye syndrome (DED) (3 arms), sponsored by Yonsei University. Primary endpoints: Tear Break Up Time at 3 months, Ocular Surface Disease Index at 3 months and 1 more. Started Aug 2017; status: completed.
02
Drugs
diquafosol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03640351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03640351.